ACOR News and Press, Acorda Therapeutics Inc. From 01/13/21

Gainers: Acorda Therapeutics (ACOR) +45%, NuCana (NCNA) +26%, Synlogic (SYBX) +24%, Evoke Pharma (EVOK) +23%, Tiziana Life Sciences (TLSA) +14%.Losers: Zomedica (ZOM) -26%, Forward Pharma (FWP) -15%, Provention Bio (PRVB) -14%, Acutu...

Acorda Therapeutics (ACOR) jumps 65% premarket after entering into an agreement for the sale of its Inbrija manufacturing operations in Chelsea, Massachusetts to Catalent (CTLT) for $80M in cash.In connection with the sale, both the companies have entered into a global supply a...

Acorda Therapeutics (ACOR) +54% after announcing agreement for sale of manufacturing operations and long-term global supply agreement.Summit Midstream Partners (SMLP) +45% after winning FERC construction OK.WiMi Hologram Cloud (WIMI) +38% on obtaining a patent for a 3D holograp...

$80 million up-front payment will substantially increase cash balance Sale, restructuring and other operating expense reductions will reduce annual operating expenses by approximately $40 million Total 2021 non-GAAP operating expense guidance expected to be $130-$140 million ...

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present at the 39 th Annual J.P. Morgan Health Care Conference on Thursday, January 14, at 5:20 PM ET. A live audio webcast of the presentation can be accessed under ...

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the January 11 th -14 th H.C. Wainwright BIOCONNECT Virtual Conference. An audio webcast of the presentation can be accessed under “Investor...

Gainers: Bionano Genomics (BNGO) +90%, Ocugen OCGN +72%, ViewRay VRAY +26%, Pandion Therapeutics PAND +25%, EyePoint Pharmaceuticals EYPT +21%.Losers: Calithera Biosciences CALA -41%, Acorda Therapeutics (ACOR) -16%, Sigilon The...

To satisfy compliance with Nasdaq's $1 minimum bid price, Acorda Therapeutics (ACOR) has completed its 1-for-6 reverse stock split.The shares will start trading on split-adjusted basis from the market open on Jan.4, 2021. Stock down 1.03% AH.Now Read: COVID-19 vaccine make...

Common Stock to Begin Trading on a Split-Adjusted Basis upon Market Open on January 4, 2021 Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares of common ...

Can These Biotech Penny Stocks Continue to Climb Amidst a Potential Covid Vaccine? Biotech penny stocks have seen increased popularity in the past few months due to Covid. On Monday, November 9th, Pfizer Inc. ( PFE Stock Report ) announced that its vaccine candidate is more than...